Merck’s Ebola shot delivers antibodies that could last 2 years or more, study finds
admin 17th April 2018 Uncategorised 0Previous studies have shown that Merck & Co.’s Ebola vaccine can act fast in human bodies and maintain an antibody response for at least one year. Now, a new study pushes that estimate to two years or more.
More: Merck’s Ebola shot delivers antibodies that could last 2 years or more, study finds
Source: fierce